CoronavirusCovid-19Health

FDA Adds Warning of Rare Neurological Syndrome to Johnson & Johnson COVID Vaccine

The Food and Drug Administration has affixed a warning to the Johnson & Johnson coronavirus vaccine, saying the shot can lead to an increased risk of Guillain–Barré syndrome, a rare neurological condition.

Though the FDA said such instances are very rare, about 100 suspected cases have been identified among the nearly 13 million people who have received the shot, Axios reported.

No such connections have been made with any other available vaccines.

Meanwhile, Johnson & Johnson officials said its coronavirus vaccine is effective against the delta variant of the virus that health experts worry could cause another surge nationwide among the unvaccinated.

The company said last week that its one-dose shot defends against the variant, citing lab tests of vaccine recipients’ blood.

Company officials speculate the immune response may last more than eight months.

The FDA temporarily paused the distribution of the Johnson & Johnson vaccine in early April after concerns of a connection to a rare blood clotting condition, but rescinded the order less than two weeks later.

 

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Adblock Detected

Please consider supporting us by disabling your ad blocker